Company announcements · 11/13/20261 min read

Leqembi® Pen subcutaneous treatment launched in Japan

Traduzzjoni awtomatika lokali · Il-lingwa oriġinali tas-sors

Illustration generated by Business News; it is not a source photograph.

Sommarju

STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…

Il-lingwa oriġinali tas-sors: PR Newswire UK — News ReleasesAqra l-oriġinal →